Tag: UAE

Vascular Imaging Market Worth $24.4 Billion By 2026

The global vascular imaging market size is expected to reach USD 24.4 billion by 2026, registering a CAGR of 4.2% over the forecast period according to a new report by Grand View Research, Inc. Increasing prevalence of cardiovascular disorders and growing technological advancements in vascular scanning devices are majorly driving the vascular imaging market. In addition, growing funding for developments in vascular imaging devices is further anticipated to fuel the market.

Recent developments in ultrasound technology including 3D visualization and handheld devices are expected to contribute to the vascular imaging market growth. Replacement of 2D technology into 3D has enabled 3D capturing of images without the movement of transducer in real-time. In addition, developments in vector-Doppler technique based on plane-wave imaging are gaining popularity. This method effectively decreases the frame rate (reduces scan-lines) required for focusing an image and more rapidly.

Increasing number of diagnostic imaging centers due to increasing patient pool is an opportunity for the manufacturers to introduce more efficient imaging technologies. Increasing developments in imaging technologies, such as X-ray based analyses and ultrasonography techniques are expected to expand the applications of vascular imaging. These modalities are highly preferred in both palliative and curative care for superior levels of healthcare.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/vascular-imaging-market

Further Key Findings from the Report Suggest:

  • By type, non-invasive segment held the largest share in vascular imaging market in 2018 owing to various advantages offered by different techniques, such as patient safety and shorter turnaround time
  • Advantages offered by CT scanners, such as enhanced spatial and temporal resolution, quick technique, and offering of multiple images from different angles with the help of x-ray tube are expected to expand the applications of this modality
  • North America dominated the vascular imaging market in 2018, owing to high prevalence of cardiovascular disorders among geriatric population and well-established healthcare facilities
  • Vascular imaging market in Asia Pacific is expected to witness lucrative growth rate over the forecast period owing to high prevalence of CVDs in lower and middle income economies
  • The key players present in the vascular imaging market are Siemens Healthineers, GE Healthcare, Koninklijke Philips N.V. Hitachi Medical Corporation , Samsung Medisun, Shimadzu Medical Systems, Hologic Inc., Abbott Laboratories, and Carestream Health Inc.

Drug Delivery Across Blood Brain Barrier Market Worth $4.6 Billion By 2026

The global drug delivery across blood brain barrier market size is expected to reach USD 4.6 billion by 2026, according to a new report by Grand View Research, Inc. registering a CAGR of 30.2% over the forecast period. Growing research, innovation, and treatment development activities to overcome the challenges faced due to the natural blood brain barrier is majorly driving the market growth.

Growing prevalence of neurological diseases, such as Parkinson’s and Alzheimer’s disease is fueling the demand for novel drug delivery technology that allows medication to cross the blood brain barrier. Limited treatment options regarding blood-brain barrier has been a big hurdle till recently. However, the growing demand for treatment and the rise in innovations that allow for safe and reliable transmission of medication across the BBB is predicted to drive the market’s growth over the forecast period.

Among the recently developed technologies, increasing permeability of the BBB via ultrasound is the most promising one that has shown safe and effective application in treating various patients with brain cancer and other neurogenetical disorders. Other novel technologies such as in-vitro BBB modeling/engineering is being used for producing a faster, reliable, and cost-effective drug delivery mechanism for overcoming the complexities of BBB.

Increasing use of engineered antibiotics are being tested as a technique for delivering cures for severe brain disorders, such as Alzheimer’s and Hunter’s disease. Such antibiotics are expected to greatly increase the convenience of treatment, in addition to the increased effectivity.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/drug-delivery-across-blood-brain-barrier-market

Further key findings from the report suggest:

  • Based on the drug delivery technology, increasing permeability of BBB segment registered significant share of the drug delivery across blood brain barrier market owing to successful ultrasound device technology that have been deemed effective in providing therapies for treating brain disorders
  • Trojan horse approach segment is expected to lead the market soon, since engineered antibodies have been observed to provide reliable and safe medical treatment for various cancer, immunity, and genetic disorder’s treatment
  • Based on application, Parkinson’s disorder segment held maximum share in the market in 2018 owing to increased incidences of the targeted disorder among the growing geriatric population worldwide. Many major economies in EU and Asia are expected to significantly observe a growth in geriatric population by 2050.
  • Asia Pacific is anticipated to lead this market over the forecast period owing to rising geriatric population that may be prone to brain disorders and opportunity for the industry players due to medical tourism in the region. However, by revenue, North America shall continue to be the largest market due to the high cost of healthcare treatment.
  • Some of the players profiled in drug delivery across blood brain barrier market include Ossianix, Inc., Insightec, Angiochem Inc., Armagen Technologies, Inc., BrainsGate, BiOasis Technologies, Inc., CarThera, F. Hoffman La-Roche, and Iproteos S.L.

Brain Mapping Instruments Market Size Worth $2.33 Billion By 2026

The global brain mapping instruments market size is anticipated to reach USD 2.33 billion by according to a new report by Grand View Research, Inc. 2026 expanding at a 5.8% CAGR over the forecast period, increasing incidence of brain ailments as well as other neurological diseases and rising adoption of advanced technology and increasing awareness of neurodiagnostic imaging is anticipated to boost the market’s growth.

Increase in the number of patients suffering from neurological diseases such as Alzheimer’s disease, epilepsy, and Traumatic Brain Injury (TBI) are anticipated to propel this market’s growth. It also includes patients who suffer from physical injuries to the brain such as concussion. According to the American Society of Neuroradiology (ASNR), more than 75% of TBI are termed as concussion due to their mild nature of occurrence. According to the University of Pittsburgh’s Brain Trauma Research Center, more than 3,00,000 concussions occurring in the U.S. annually, are mainly sports related.

Technological advancement includes 3D brain images using Magnetic Resonance Imaging (MRI). Medtronic started a project that aims to personalized 3D brain images to help neurosurgeons. This project aims to use MRI data known as Resting-State Functional MRI (rsfMRI). This technique helps surgeons to detect typical functioning areas of brain with 3D images of brain’s anatomy. Thus, this project helps surgeons to remove brain tumor with minimal risk.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/brain-mapping-instruments-market

Further key findings from the study suggest:

  • Computed Axial Tomography (CAT) dominated the market segment in 2018 with the highest market share owing its assistance to doctors by providing them accurate 3D images of the internal organs and structures of the body such as, small nodules or tumors which cannot be seen by a normal X-ray.
  • North America dominated the brain mapping instruments market with the highest revenue share in 2018 owing to the technological advancements, awareness of brain mapping instruments and rising health concerns in the region.
  • The key players have launched technologically enhanced products to gain competitive advantage in the industry. For instance, in 2016, Koninklijke Philips N.V., launched its IntelliSpace Portal 9.0 which is designed to offer analysis to track certain neurological applications and compare brain images to determine patient progression. It helps radiologists to detect, diagnose and follow-up certain treatment of diseases.

Bioburden Testing Market Worth $2.01 Billion By 2026

The global bioburden testing market size is expected to reach USD 2.01 billion by 2026, expanding at a CAGR of 13.7% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to showcase upward trend in the forthcoming years owing to growing concerns about product safety. This has led to various government initiatives to promote microbiological safety testing tools.

A number of publications released by organizations to promote awareness regarding microbiological safety testing is broadening the future growth prospects of bioburden testing. For instance, the U.S. Department of Health and Human Services and Centers for Disease Control published Biosafety in Microbiological and Biomedical Laboratories (BMBL), which includes information pertaining to laboratory biosecurity and risk assessment, decontamination and sterilization, and biological toxins and biosafety levels in laboratories.

Growth of pharmaceutical, biotechnology, medical device, and food and beverage industries have contributed to the high growth of the bioburden testing market. In addition, increase in R&D investments by prominent companies is expected to encourage end users to adopt highly efficient bioburden testing tools to counter possible losses due to microbial contamination. Merck is planning to invest USD 16 billion in R&D over the next five years, in addition to its annual investment of USD 7 billion. Moreover, requirement for basic drug safety data requirements for preclinical studies is expected to fuel the demand for bioburden testing tools.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/bioburden-testing-market

Further key findings from the study suggest:

  • On the basis of product, consumables segment dominated the market in 2018 owing to a wide use of culture media and reagents and kits
  • PCR instruments facilitate rapid analysis of bacterial bioburden, thus, fostering high market growth
  • Aerobic count testing held significant market share in 2018 due to easy isolation of aerobic bacteria by culture media
  • Raw material testing is anticipated to showcase lucrative growth during the forecast period owing to the increasing number of product recalls and concern regarding product quality
  • On the basis of end use, pharmaceutical and biotechnology companies dominated the market in 2018 owing to the high growth of this industry
  • The number of CMOs is increasing significantly, which has led to a rise in outsourcing services, thus, driving the segment growth
  • North America held the largest revenue share in 2018 due to high R&D spending by key companies and high healthcare spending in the U.S.
  • Some of the key manufacturers in the bioburden testing market include Charles River Laboratories International, Inc.; SGS SA; Merck KGaA; Becton, Dickinson and Company; and Wuxi Apptec

Cardiac Surgery Instruments Market Size Worth $2.7 Billion By 2026

The global cardiac surgery instruments market size is expected to reach USD 2.7 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 6.6%. Increase in the number of cardiac surgeries & procedures and technological advancements are some factors expected to drive the market. Moreover, high incidence of cardiac diseases and availability of various surgical procedures are expected to boost the adoption of cardiac surgery instruments during the forecast period.

Technological advancements in the field of cardiac surgery instruments are considered a key driver of this market. Several key players are investing in R&D for launching innovative and novel products. Moreover, sedentary & poor lifestyle, which result in diabetes, obesity, & poor diet; smoking; and excessive alcohol consumption have also increased the predisposition to heart diseases.

Furthermore, increase in aging population and rising healthcare expenditure in emerging economies are among the factors likely to boost the number of cardiac surgeries during the forecast period. These factors are anticipated to positively influence revenue generation. According to the U.S. Census Bureau, the global healthcare spending is anticipated to increase to USD 18.28 trillion by 2040, growing at a CAGR of 2.6%. According to WHO, the world’s population aged 60 years and above is expected to reach 2 billion by 2050, from 900 million in 2015.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/cardiac-surgery-instruments-market

Further key findings from the report suggest:

  • North America accounted for the largest share of over 40.0%, owing to favorable reimbursement policies, local presence of key players, and increase in number of heart patients as well as government initiatives
  • Asian countries are estimated to show highest growth rate, driven by advancing technology, increasing investments, improving reimbursement scenarios, low cost of treatment, and increasing medical tourism
  • Forceps segment accounted for the highest share and is expected to exhibit the highest growth rate
  • Based on application, coronary artery bypass grafting captured the largest share and is expected to be the fastest growing segment
  • Some of the major players are KLS Martin Group; Sklar Surgical Instruments; B. Braun Melsungen AG; Teleflex Incorporated; Symmetry Surgical, Inc; STILLE; Cardivon Surgical Inc.; Delacroix-Chevalier (France); Boss Instruments Ltd (U.S.); Wexler Surgical (U.S.); Medicon eG (Germany); Surgins (U.K.); Scanlan International (U.S.); Rumex International Co. (U.S.); and SIM Surgical (U.S.).

Dental Syringes Market Size Worth $10.85 Billion By 2026

The global dental syringes market size is expected to reach USD 10.85 billion by 2026, registering a CAGR of 4.8% over the forecast period, according to a new report by Grand View Research, Inc. Increasing product innovationsare expected to drive the market growth. In addition, rising prevalence of dental and oral diseases, such as periodontitis, dental caries, and oral cancer is anticipated to fuel the growth.

Practicon recently introduced new design called Pike Anesthetic Syringe. When retracted, the plunger on this syringe separates the harpoon and the stopper through its modified sleeve. This design avoids the hassle of pulling the rubber stopper completely out of the syringe while changing the cartridges. This makes the product safe as well as efficient. The product is compatible with the regular anesthetic needles and carpules. Such innovations are projected to drive the market growth in the forthcoming years.

Growing population in countries from Asia Pacific, such as China and India is anticipated to create market expansion opportunities in near future. Factors such as a rise in geriatric population and poor dietary habits are expected to increase the prevalence of dental diseases, which in turn is expected to fuel the demand for dental syringes. Rising burden of dental diseases in India is expected to create growth opportunities. According to the Indian Journal of Dental Research, approximately 31,426 males and 34,426 females out of every 100,000 people in India suffer from dental caries. Such high prevalence is expected to boost the product demand, thereby fueling the market growth.

However, the lack of skilled dentists is anticipated to hamper growth of the dental syringes market in near future. Nonetheless, factors such as growing number of professionals, awareness among dental healthcare providers regarding the advantages of using innovative dental syringes is expected to create growth opportunities for the market over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/dental-syringes-market

Further key findings from the report suggest:

  • Reusable syringe product segment held the largest market share in 2918, due to the prevalence of periodontitis, preference by dental surgeons for the delivery of anesthesia, and cost-efficiency of these syringes
  • Disposable syringe is expected to be the fastest-growing product segment in the next seven years owing to the rising focus on hygiene during dental surgery
  • Non-aspirating syringes type is expected to hold a significant market share over the forecast period, owing to high product efficiency
  • Asia Pacific is expected to be the fastest-growing market in the forthcoming years owing to the factors such as rising medical tourism, improving healthcare facilities, and increasing consumer disposable income
  • Few players in the dental syringes market include A.Titan Instruments, Inc.; Integra LifeSciences Corporation; Septodont; 3M Company; Power Dental USA, Inc.; Dentsply Sirona; and Vista Dental Products

Wheelchair Market Size Worth $4.2 Billion By 2026

The global wheelchair market size is expected to reach USD 4.2 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.6%. Growing disabled population along with rising geriatric population is among factors driving market growth. In addition, improvements in healthcare infrastructure are fueling the demand for wheelchairs.

Adoption and awareness of advanced wheelchairs products are also propelling growth. Growing integration of automation in healthcare devices, especially mobility devices, such as wheelchairs, is anticipated to boost growth. For instance, wheelchairs are integrated with non-linear processing circuits, guide sensors, pulse steering drive, and several controls for making the ride easy and smooth for patients.

Rising prevalence of lifestyle diseases, osteoporosis, and other autoimmune disorders that lead to the need for wheelchairs and growing baby boomers are also some factors driving the market. Presence of geriatric population is one of the key factors responsible for the largest share held by U.S. in North America.

Hospital segment held the maximum share in 2018. This can be attributed to rising high-end mobility equipment such as powered wheelchairs and manual wheelchairs, which are preferred by patients in different healthcare settings as these wheelchairs offer required mobility during hospital stays.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/wheelchair-market

Further key findings from the study suggest:

  • Manual wheelchairs held the largest share in 2018 owing to their increasing use in hospitals
  • Features of electric wheelchairs such as superior quality braking system, especially to stop accidental rolling, self-reliance, and comfortability are anticipated to boost growth
  • Increase in medical emergencies is one of the key factors driving wheelchair market growth
  • Rising number of rheumatoid arthritis and osteoporosis procedures is expected to boost demand for rehabilitation wheelchairs
  • Adults segment held the largest share in 2018 due to presence of a high global geriatric population and rise in the prevalence of conditions requiring different types of mobility devices
  • North America dominated the market due to increased adoption of advanced technology in wheelchairs and rise in disabled population
  • Some of the players operating in the market are Carex Health Brands, Inc.; Drive Medical Design & Manufacturing; Graham-Field Health Products, Inc.; Invacare; Medline; Sunrise Medical LLC; Karman Healthcare; Quantum Rehab; Numotion; and Pride Mobility Products Corp.

Recreational Oxygen Equipment Market Worth $299.8 Million By 2026

The global recreational oxygen equipment market size is expected to reach USD 299.8 million by 2026, according to a new report by Grand View Research, Inc., registering a CAGR of 16.2% over the forecast period. High prevalence of unhealthy lifestyle among a large section of the global population has increased the risk of respiratory disorders such as chronic obstructive pulmonary disease (COPD). This is a major factor driving the need for recreational oxygen equipment. In addition, growing geriatric population, who is prone to numerous health disorders requiring supplemental oxygen, is expected to boost the market.

Consumer oxygen efficiently treats dementia and muscle recovery. Increase in awareness levels pertinent to the benefits of consumer O2 in the treatment of Obesity Hypoventilation Syndrome (OHS), COPD, dementia, and stress are projected to drive demand in the coming years. In 2015, the total population suffering from dementia was pegged at 47.47 million and is anticipated to rise to 75.63 million by over the next seven years. This represents lucrative opportunities for manufacturers in the field.

Recreational oxygen is also helpful during strenuous physical activities such as mountain climbing, where the altitude makes it difficult to breathe normally. Apart from this, these products have also been utilized in other recreational sports like skiing, hiking, biking, snowboarding, or floating at altitude. Owing to increasing popularity of these sports, demand for portable O2 devices for recreational use is on the rise. However, low awareness regarding the benefits of these devices in underdeveloped economies is hampering market growth. Key players in the market are focusing on creating awareness among consumers for medical as well as sports use, especially in untapped regions. This will help them establish a strong market presence over the course of the forecast period.

Companies are also investing in developing new, more effective, and innovative equipment to gain a foothold in the market. For instance, Sub Sea Systems installed the world’s first underwater oxygen bar in Cozumel, Mexico in April 2015. This underwater attraction is designed to give customers the experience of being in a 13,000-gallon aquarium to play games and take pictures, all the while breathing in enriched O2.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/recreational-oxygen-equipment-market

Further key findings from the study suggest:

  • Portable oxygen concentrators accounted for the largest revenue share by product in 2018. Manufacturers have been focusing on manufacturing compact, stylish portable oxygen concentrators to cater to changing consumer demands. This segment is also expected to exhibit the fastest growth over the forecast period
  • The athletics segment is expected to witness lucrative growth in the coming years. Professional athletes have been increasingly adopting this equipment owing to availability of portable and user-friendly products
  • New product launch has been the focus of manufacturers in the market. Key industry participants include Oxygen Plus, Inc.; Boost Oxygen, LLC; Koninklijke Philips N.V.; Chart Industries; and Inogen.

Prosthetic Liners Market Worth $369.81 Million By 2026

The global prosthetic liners market size is expected to reach USD 369.81 million by 2026, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.1% during the forecast period. Rising prevalence of osteoarthritis, orthopedic injuries and other extremities that require prosthetics is expected to drive the product demand.

In addition, a paradigm shift toward cost-effective and durable materials used in prosthetic procedures is anticipated to fuel the market growth. Rise in road traffic accidents and sports injuries can be attributed to the growing demand for prosthetic procedures. This factor is projected to drive the demand for prosthetic liners over the forecast period.

Strategic initiatives such as technologically advanced product launch, mergers & acquisitions, and collaborative agreements are adopted by the market participants to gain greater market share. For instance, in July 2018, Blatchford announced the launch of Orion3 programming app for clinicians via Bluetooth for enabling faster and straight forward limb setup available on iOS. This innovative app provides reliable connectivity. Such initiatives are expected to boost the growth of the prosthetic liners market over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/prosthetic-liners-market

Further key findings from the report suggest:

  • Silicone material is the most preferred material for prosthetic liner manufacturing and hence accounted for the largest market share in terms of revenue in 2018
  • Upper extremity led the prosthetic liners market in 2018, owing to rising application of the product as they offer rapid and painless recovery. It also helps regain normal functioning of the affected area within a short period. Major companies manufacturing this product are Zimmer Biomet Holdings Inc.; Blatchford Inc., and Össur
  • Hospitals accounted for the largest revenue share in 2018 due to the availability of highly skilled professionals and an increasing number of orthopedic surgeries performed in these settings
  • North America registered the dominant market share in 2018, due to the presence of a large number of industry players and supportive government initiatives
  • Asia Pacific is expected to witness the fastest CAGR over the forecast period owing to increasing number of target population and awareness among prosthetists regarding the benefits of liners for better health outcomes
  • Some of the key market players are Blathford Inc.; Fillauer LLC; Ottobock Healthcare GmbH; WilliowWood Company; and Zimmer Biomet

Life Science Analytics Market Worth $13.2 Billion By 2027

The global life science analytics market size is expected to reach USD 13.2 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.9% from 2020 to 2027. Rising applications of advanced analytics in life science applications and increasing demand from pharmaceutical and medical device industry are the major parameters driving the market. Analytics are used widely used in the life science analytics industry to assess risk, assessment of the effectiveness of clinical trials, provide personalized medicine, develop faster and more productive research and development pipeline, forecasting profits, budgeting, controlling product price, and predict virus evolution.

Rising adoption of big data and artificial intelligence in the healthcare sector is estimated to drive the market during the forecast period. A survey conducted by Applied Clinical Trials in 2016 depicted that 58.0% of the clinical trials industry professionals considers big data in clinical trials as extremely important while 32.0% considered it moderately important. Furthermore, the growing impact of social media on healthcare sector is fueling the growth of the market. As of 2016, the CDC has 18 Facebook profiles with a reach of 370,000 populations; YouTube channel with over 8.8 million public views; 13 blogs; LinkedIn accounts; mobile apps, and many other reaches through social networking. The concept of social media is enabling the organizations to facilitate the integration of multiple information in a platform, rationalize the cost, and better targeting of providers and consumers (or patients).

mHealth, Electronic Health Records (EHR), eHealth, and mobile applications along with artificial and human intelligence data analytics are offering opportunities for customization of medical approaches, which in turn is increasing demand for data analytic tools in the life science industry over the forecast period. According to Personalized Medicine Coalition, the number of drugs manufactured by personal medicine approaches has grown by 62%, since 2012.Moreover, strategies adopted by key players such as partnerships, product launches, collaborations, mergers & acquisitions, and government initiatives is further boosting the market. For instance, in April 2016, IBM acquired Truven Health Analytics, a leading provider of cloud-based healthcare data and analytics, to strengthen its Watson Health portfolio. This was expected to give the company access to over 8,500 clients of Truven Health Analytics.

The report “Life Science Analytics Market Size, Share & Trends Analysis Report By Component, By Type (Reporting, Descriptive, Predictive, Prescriptive), By Application, By Delivery, By End User, By region, And Segment Forecasts, 2020 – 2027” is available now to Grand View Research customers and can also be purchased directly fromhttp://www.grandviewresearch.com/industry-analysis/life-science-analytics-market

Click the link below:
https://www.grandviewresearch.com/industry-analysis/life-science-analytics-market

Further key findings from the report suggest:

  • Descriptive analytics type emerged as leading ingredient typesegment in 2019 with a revenue share of 36.0% in the market
  • Based on components, the services segment accounted for the largest revenue share in 2019, and is also projected to expand at fastest CAGR during the forecast period
  • Amongst application segment, sales and marketing support accounted for the largest revenue share in 2019, whereas research and development is projected to expand at fastest CAGR during the forecast period
  • Amongst delivery segment,on-premises accounted for the largest revenue share in 2019, whereas on-demand is projected to expand at fastest CAGR during the forecast period
  • Based on end-user, the pharmaceuticals segment accounted for the largest revenue share in 2019, whereas biotechnology is projected to expand at fastest CAGR during the forecast period
  • North America accounted for the largest revenue share due to increasing government support and growing demand for analytics from life science companies